Showing results (851-860 of 1,351) with videos related to
Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|July 21, 2017
Population Pharmacokinetics of Lenalidomide in Healthy Volunteers and Patients With Hematologic MalignanciesJamie N Connarn, Renfang Hwang, Yue Gao, et al.Clinical Pharmacology in Drug Development|August 8, 2017
Cardiac Safety of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator: Results of a Thorough QT/QTc StudyJonathan Q Tran, Jeffrey P Hartung, Allan D Olson, et al.Clinical Pharmacology in Drug Development|November 8, 2017
In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF-00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid ReceptorSharon L Ripp, Arnab Mukherjee, Heather Eng, et al.Clinical Pharmacology in Drug Development|October 13, 2017
The Relative Bioavailability, Food Effect, and Drug Interaction With Omeprazole of Momelotinib Tablet Formulation in Healthy SubjectsYan Xin, Lixin Shao, Julie Maltzman, et al.Clinical Pharmacology in Drug Development|November 11, 2017
Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets TechnologyJacob Atsmon, Daphna Heffetz, Lisa Deutsch, et al.Clinical Pharmacology in Drug Development|November 11, 2017
Effects of High- and Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor ModulatorJonathan Q Tran, Jeffrey P Hartung, Cindy-Ann Tompkins, et al.Clinical Pharmacology in Drug Development|September 8, 2017
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF-06252616), an Antimyostatin Monoclonal Antibody, in Healthy SubjectsIndranil Bhattacharya, Sylvester Pawlak, Shannon Marraffino, et al.Clinical Pharmacology in Drug Development|May 11, 2016
Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy SubjectsYing Jun Cao, Taiji Sawamoto, Udaya Valluri, et al.Clinical Pharmacology in Drug Development|May 11, 2016
Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical StudiesPaul Martin, Michael Gillen, David Millson, et al.Clinical Pharmacology in Drug Development|May 11, 2016
A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male SubjectsAjit Suri, Theresa Pham, David B MacLeanPageof 136